About the Authors
- David N. Juurlink
-
* E-mail: dnj@ices.on.ca
Affiliations Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada, Sunnybrook Research Institute, Toronto, Ontario, Canada, Department of Medicine, University of Toronto, Toronto, Ontario, Canada, Department of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada
- Colin R. Dormuth
-
Affiliation University of British Columbia, Vancouver, British Columbia, Canada
- Anjie Huang
-
Affiliation Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada
- Chelsea Hellings
-
Affiliation Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada
- J. Michael Paterson
-
Affiliations Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada, Department of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada, Department of Family Medicine, McMaster University, Hamilton, Ontario, Canada, Centre for Evaluation of Medicines, St. Joseph’s Healthcare, Hamilton, Ontario, Canada
- Colette Raymond
-
Affiliations Manitoba Centre for Health Policy, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada, Winnipeg Regional Health Authority, Winnipeg, Manitoba, Canada
- Anita Kozyrskyj
-
Affiliations Manitoba Centre for Health Policy, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada, Winnipeg Regional Health Authority, Winnipeg, Manitoba, Canada, Women and Children’s Research Institute and the Department of Pediatrics, Faculty of Medicine & Dentistry, University of Alberta, Calgary, Alberta, Canada
- Yola Moride
-
Affiliation Faculty of Pharmacy, Université de Montréal, Montréal, Quebec, Canada
- Erin M. Macdonald
-
Affiliation Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada
- Muhammad M. Mamdani
-
Affiliations Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada, Keenan Research Centre of the Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Toronto, Ontario, Canada, Department of Medicine, University of Toronto, Toronto, Ontario, Canada, Department of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada
Competing Interests
Muhammad Mamdani has the following conflicts: he has served on Advisory Boards for Hoffman La Roche, Glaxo Smith Kline, Eli Lilly and Company, Bristol-Myers Squibb, Novartis, Novo Nordisk, AstraZeneca and Pfizer. The authors used the Drug Product and Therapeutic Class Database from Brogan Inc., Ottawa in this study. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: DNJ CD JMP MMM CH. Performed the experiments: AH. Analyzed the data: DNJ AH CH JMP MMM CR AK YM CD EMM. Wrote the manuscript: DNJ AH CH JMP MMM CR AK YM CD EMM.